Heterozygous recipient and donor HFE mutations associated with a hereditary haemochromatosis phenotype after liver transplantation

Gut

Volumn 52, Issue 3, 2003, Pages 433-435

  Wigg, A J ^a   Harley, H ^b   Casey, G ^c  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HFE PROTEIN; SERINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; EXON; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HUMAN; IRON OVERLOAD; LIVER TRANSPLANTATION; MALE; MISSENSE MUTATION; ORGAN DONOR; PHENOTYPE; PRIORITY JOURNAL;

ADULT; BASE SEQUENCE; FEMALE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER TRANSPLANTATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE;

EID: 0037371187     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.3.433     Document Type: Article

References (20)

1. Alanen KW, Chakrabati S, Rawlins JJ, et al. Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors. Hepatology 1999;30:665-9.
2. Pointon JJ, Wallace D, Merryweather-Clarke AT, et al. Uncommon mutations and polymorphisms in the haemochromatosis gene. Genetic Testing 2000;4:151-61.
3. Piperno A, Arosio C, Fossati L, et al. Two novel nonsense mutations of HFE gene in five unrelated Italian patients with hemochromatosis. Gastroenterology 2000;119:441-5.
4. Steiner M, Ocran K, Genschel J, et al. A homozygous HFE gene splice site mutation in a hereditary hemochromatosis patient of Vietnamese origin. Gastroenterology 2002;122:789-95.
5. Arnold A, Horst SA, Gardella TJ, et al. Mutation of the signal petide-encoding region of the preproparathyroid gene in familial isolated hypoparathyroidism. J Clin Invest 1990;86:1084-7.
6. Strmecki L, Benedik-Dolincar M, Vouk K, et al. Screen of 55 Slovevian hemophilia A patients: identification of 2 novel mutations (S-1R and IVS23+1G→A) and discussion of mutation spectrum. Hum Mutat 1999;13:413.
7. Loubser O, Marais AD, Kotze MJ, et al. Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolaemia phenotype in the indigenous South African population of mixed ancestry. Clin Genet 1999;55:340-5.
8. Crawford DHG, Jazwinska EC, Cullen LM, et al. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998;114:1003-8.
9. Roetto A, Alberti F, Daraio F, et al. Exclusion of ZIRTL as candidate gene of juveile hemochromatosis and refinement of the critical interval on 1q21. Blood Cells Mol Dis 2000;26:205-10.
10. Girelli D, Bozzini C, Roetto A. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterology 2002;122:1295-302.
11. Njajou OT, Vaessen N, Joosse M, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001;28:213-14.
12. Monlosi G, Donovan A, Totaro A, et al. Autosomal dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-23.
13. Wallace DF, Pederson P, Dixon JL, et al. Novel mutation in ferroportin 1 is associated with autosomal dominant hemochromatosis. Blood 2002;100:692-4.
14. Devalia V, Carter K, Walker AP, et al. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 2002;100:695-7.
15. Powell LW. Does transplantation of the liver cure genetic hemochromatosis? J Hepatol 1992;16:259-61.
16. Dietze O, Vogel W, Braunsperger B, et al. Liver transplantation in idiopathic hemochromatosis. Transplant Proc 1990;22:1512-13.
17. Adams PC, Ghent CN, Grant DR, et al. Transplantation of a donor liver with haemochromatosis: evidence against an inherited intrahepatic defect. Gut 1991;32:1082-3.
18. Dabkowski PL, Angus PW, Smallwood RA, et al. Site of principal metabolic defect in idiopathic haemochromatosis:insights from transplantation of an affected organ. BMJ 1993:306:1726.
19. Koskinas J, Portmann B, Lombard M, et al. Persistent iron overload 4 years after inadvertent transplantation of a haemochromatotic liver in a patient with primary biliary cirrhosis. J Hepatol 1992;16:351-4.
20. Adams PC, Jeffrey G, Alanen K, et al. Transplantation of haemochromatosis liver and intestine into a normal recipient. Gut 1999;45:783.